On a CT scan, a stroke appears as either a bright white area (hemorrhagic stroke, caused by bleeding) or a dark area (ischemic stroke, caused by a blocked blood vessel). The type of stroke determines the appearance, and the timing of the scan matters enormously because ischemic strokes can be nearly invisible in the first few hours.
Hemorrhagic Stroke: The Bright White Spot
Hemorrhagic strokes are the easiest to spot. Fresh blood clots rapidly after bleeding into the brain and shows up as a bright, hyperdense (white) area on a non-contrast CT scan. This high-density appearance stands out sharply against the surrounding gray brain tissue. The location and size of the bright area tell doctors where the bleeding occurred and how much damage it may cause. Surrounding the white area, you may also see darker zones where the brain tissue is swelling in response to the bleed.
This is the primary reason CT scans are the first imaging test in a suspected stroke. The scan takes only minutes, and ruling out bleeding is critical because the treatment for an ischemic stroke (clot-busting medication) would be dangerous if the stroke were actually caused by a hemorrhage. Non-contrast CT is highly accurate at detecting fresh blood, making it the standard first step in emergency stroke care worldwide.
Ischemic Stroke: Subtle and Time-Dependent
Ischemic strokes, which account for roughly 87% of all strokes, are far harder to see on a CT scan, especially early on. When a blood vessel is blocked, brain tissue starts to die from lack of oxygen, but the changes on CT develop gradually. In the first three hours after symptoms begin, a CT scan may look completely normal. One large study found that only 29% of patients scanned within three hours showed visible changes, compared to 54% of those scanned between four and eight hours.
When early signs do appear, they’re subtle. Doctors look for several specific clues:
- Loss of gray-white differentiation. Normally, gray matter (the brain’s outer layer) and white matter (the deeper tissue) have slightly different densities on CT. In an ischemic stroke, this contrast blurs as the affected tissue swells with fluid.
- Slight darkening of brain tissue. The oxygen-starved area becomes slightly less dense than normal brain, appearing as a faint dark patch. This is especially telling when it appears in the insular cortex (a strip of tissue deep in the brain’s side) or the lenticular nucleus (a structure in the basal ganglia).
- Sulcal effacement. The grooves on the brain’s surface, called sulci, normally appear as thin dark lines. When brain tissue swells, these grooves get compressed and disappear.
Overall sensitivity of CT for ischemic stroke within six hours is about 75%, meaning one in four early ischemic strokes won’t be visible. When CT does show ischemic changes, though, it’s essentially always a true positive.
The Hyperdense Artery Sign
One of the earliest and most distinctive markers of an ischemic stroke is the “hyperdense vessel sign,” most commonly seen in the middle cerebral artery, one of the brain’s major blood suppliers. On a CT scan, the clot-filled artery appears as a bright white line or dot, brighter than the same artery on the opposite side of the brain. Technically, the affected segment measures higher than 43 Hounsfield units (the density scale CT uses) and at least 1.2 times denser than the matching artery on the other side.
This sign is highly specific, meaning when you see it, a large vessel blockage is almost certainly present. But it’s not very sensitive, so many ischemic strokes won’t show it. When it does appear, it tends to predict a worse outcome: larger areas of brain damage, more severe neurological deficits, and higher mortality.
How the Appearance Changes Over Days and Weeks
A stroke doesn’t look the same on every scan. The appearance evolves through three broad stages.
In the acute phase (first 24 hours), the changes described above may be subtle or absent. As the stroke enters the subacute phase (roughly 24 hours to five days), the picture becomes much clearer. The affected area darkens further as fluid accumulates in the damaged tissue, and the borders of the stroke become more sharply defined. Swelling peaks during this stage, and the mass effect (pressure from the swollen tissue pushing against surrounding structures) is at its greatest. This is when the risk of dangerous brain herniation is highest.
In the chronic phase (weeks and beyond), the swelling resolves and the dead brain tissue is gradually reabsorbed. What remains is a clearly dark area, often with visible shrinkage of the brain in that region. The space left behind may fill with cerebrospinal fluid, leaving a permanent dark pocket on future scans.
How Doctors Score What They See
Radiologists don’t just eyeball the scan. For strokes involving the middle cerebral artery territory, they often use a standardized scoring system called ASPECTS (Alberta Stroke Program Early CT Score). This divides the at-risk brain region into 10 zones, including the caudate, putamen, internal capsule, insular cortex, and six cortical regions. The score starts at 10 (normal scan), and one point is subtracted for each zone showing early stroke changes.
A score of 7 or below predicts worse functional outcomes at three months and a higher risk of bleeding complications from treatment. A score above 3 is associated with much better survival, with nearly 94% of those patients surviving the initial event. This score plays a direct role in treatment decisions, particularly whether a patient is a good candidate for clot removal procedures.
Advanced CT Techniques Beyond the Basic Scan
The plain, non-contrast CT is just the starting point. In many stroke centers, it’s immediately followed by two additional CT-based tests that provide more information without switching to a different machine.
CT angiography (CTA) involves injecting contrast dye to visualize the blood vessels directly. This shows exactly where a blockage is located and how large it is, which is essential for deciding whether a mechanical clot-retrieval procedure is appropriate.
CT perfusion (CTP) goes a step further by mapping blood flow through the brain in real time. It generates color-coded maps showing which areas have reduced blood flow. The key distinction it reveals is between brain tissue that’s already dead (the core) and tissue that’s starving but still salvageable (the penumbra). The penumbra is the treatment target. One of the most useful measurements is mean transit time, which tracks how long it takes blood to pass through a region. Tissue where transit time exceeds roughly 12 to 13.5 seconds compared to normal is at high risk of dying without intervention. This perfusion data can extend the treatment window well beyond the traditional time limits by showing that salvageable tissue still exists.
What Else Can Look Like a Stroke on CT
Several conditions can mimic stroke both clinically and on imaging. Brain tumors, particularly small ones located in the cortex along an arterial territory, can be mistaken for subacute infarcts, especially when they have variable patterns of contrast enhancement. Cerebral venous thrombosis (a clot in the brain’s drainage veins rather than its supply arteries) causes swelling and sometimes bleeding, but the affected area doesn’t follow the typical arterial territory pattern, which is the key distinguishing feature.
Posterior reversible encephalopathy syndrome (PRES) produces areas of swelling that can look alarming on CT, but the changes are typically bilateral, concentrated in the back of the brain, and reversible with treatment. Brain infections like abscesses or encephalitis can also create dark areas resembling ischemic stroke. Even chronic subdural hematomas, collections of old blood on the brain’s surface, can produce stroke-like symptoms including confusion, difficulty walking, and one-sided weakness.
This is why the CT scan is always interpreted alongside the clinical picture: when symptoms started, how they progressed, and what the neurological exam shows. The scan alone rarely tells the complete story, but it remains the fastest and most reliable first step in distinguishing between stroke types and ruling out conditions that require entirely different treatments.